Drug-induced liver injury following positive drug rechallenge
Authors:
- 1 June 2009
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 54 (1) , 84-90
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Drug-Induced Liver InjuryDrug Safety, 2007
- Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registryHepatology, 2006
- Monitoring and management of antituberculosis drug induced hepatotoxicityJournal of Gastroenterology and Hepatology, 2005
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- The role of scientific evidence of risks and benefits in determining risk management policies for medicationsPharmacoepidemiology and Drug Safety, 2003
- Effect of interferon α‐ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N‐acetyltransferase‐2 activities in patients with chronic active hepatitis CClinical Pharmacology & Therapeutics, 2002
- Drug–Induced Liver Injury: Mechanisms and Test SystemsHepatology, 2001
- Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactionsJournal of Hepatology, 2000
- Accuracy of hepatic adverse drug reaction reporting in one English health regionBMJ, 1999
- Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis*Clinical Pharmacology & Therapeutics, 1997